| Invasive aspergillosis in solid‐organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice S Husain, JF Camargo Clinical transplantation 33 (9), e13544, 2019 | 216 | 2019 |
| CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms MJ Dolan, H Kulkarni, JF Camargo, W He, A Smith, JM Anaya, T Miura, ... Nature immunology 8 (12), 1324-1336, 2007 | 207 | 2007 |
| COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis of current literature MA Raja, MA Mendoza, A Villavicencio, S Anjan, JM Reynolds, ... Transplantation Reviews 35 (1), 100588, 2021 | 206 | 2021 |
| CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1–infected individuals SK Ahuja, H Kulkarni, G Catano, BK Agan, JF Camargo, W He, ... Nature medicine 14 (4), 413-420, 2008 | 148 | 2008 |
| Emerging concepts in cytomegalovirus infection following hematopoietic stem cell transplantation JF Camargo, KV Komanduri Hematology/oncology and stem cell therapy 10 (4), 233-238, 2017 | 120 | 2017 |
| CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus M Mamtani, B Rovin, R Brey, JF Camargo, H Kulkarni, M Herrera, ... Annals of the rheumatic diseases 67 (8), 1076-1083, 2008 | 120 | 2008 |
| Interleukin-1β polymorphisms in Colombian patients with autoimmune rheumatic diseases JF Camargo, PA Correa, J Castiblanco, JM Anaya Genes & immunity 5 (8), 609-614, 2004 | 111 | 2004 |
| CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation JF Camargo, MP Quinones, S Mummidi, S Srinivas, AA Gaitan, K Begum, ... The Journal of Immunology 182 (1), 171-182, 2009 | 108 | 2009 |
| Immune correlates of protection in human invasive aspergillosis JF Camargo, S Husain Clinical infectious diseases 59 (4), 569-577, 2014 | 101 | 2014 |
| Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial DJ Winston, KM Mullane, OA Cornely, MJ Boeckh, JW Brown, SA Pergam, ... The Lancet 391 (10135), 2116-2127, 2018 | 100 | 2018 |
| Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1–infected individuals JF Okulicz, TD Le, BK Agan, JF Camargo, ML Landrum, E Wright, ... JAMA internal medicine 175 (1), 88-99, 2015 | 98 | 2015 |
| Analysis of IL1B, TAP1, TAP2 and IKBL polymorphisms on susceptibility to tuberculosis LM Gomez, JF Camargo, J Castiblanco, EA Ruiz‐Narváez, J Cadena, ... Tissue antigens 67 (4), 290-296, 2006 | 85 | 2006 |
| Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature JF Camargo, GJ Tobón, N Fonseca, JL Diaz, M Uribe, F Molina, JM Anaya Lupus 14 (4), 315-320, 2005 | 80 | 2005 |
| Potential role of deer tick virus in Powassan encephalitis cases in Lyme disease–endemic areas of New York, USA MY El Khoury, JF Camargo, JL White, BP Backenson, AP Dupuis, ... Emerging infectious diseases 19 (12), 1926, 2013 | 74 | 2013 |
| Successful treatment of carbapenemase-producing pandrug-resistant Klebsiella pneumoniae bacteremia JF Camargo, J Simkins, T Beduschi, A Tekin, L Aragon, A Pérez-Cardona, ... Antimicrobial agents and chemotherapy 59 (10), 5903-5908, 2015 | 71 | 2015 |
| Next generation sequencing of microbial cell-free DNA for rapid noninvasive diagnosis of infectious diseases in immunocompromised hosts JF Camargo, A Ahmed, MI Morris, S Anjan, CE Prado, OV Martinez, ... Biology of Blood and Marrow Transplantation 25 (3), S356-S357, 2019 | 69 | 2019 |
| MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature JF Camargo, SA Lobo, AP Hsu, CS Zerbe, GP Wormser, SM Holland Clinical infectious diseases: an official publication of the Infectious …, 2013 | 65 | 2013 |
| Impact of cytomegalovirus viral load on probability of spontaneous clearance and response to preemptive therapy in allogeneic stem cell transplantation recipients JF Camargo, E Kimble, R Rosa, LA Shimose, MX Bueno, N Jeyakumar, ... Biology of Blood and Marrow Transplantation 24 (4), 806-814, 2018 | 61 | 2018 |
| Responsiveness of T Cells to Interleukin‐7 Is Associated with Higher CD4+ T Cell Counts in HIV‐1–Positive Individuals with Highly Active Antiretroviral Therapy … JF Camargo, H Kulkarni, BK Agan, AA Gaitan, LA Beachy, S Srinivas, ... The Journal of infectious diseases 199 (12), 1872-1882, 2009 | 61 | 2009 |
| Clinical “real‐world” experience with letermovir for prevention of cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients A Anderson, M Raja, N Vazquez, M Morris, K Komanduri, J Camargo Clinical transplantation 34 (7), e13866, 2020 | 59 | 2020 |
